drugset / Trial / NCT00608569

Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults

NCT00608569

RandomizedParallel-groupOpen-labelPrevention

Summary

Highly active antiretroviral therapy (HAART) has led to better health and survival rates among people with HIV/AIDS. The purpose of this study was to measure the effect of trained partner supervision when taking medication versus self-administered therapy in HIV infected participants. These participants have had their first virologic failure on a non-nucleoside reverse transcriptase inhibitor (NNRTI)-based HAART regimen and were starting a protease inhibitor (PI)-based HAART regimen at study entry.

Timeline

Start
2009-03
Primary completion
2012-09
Completion
2012-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Emtricitabine/Tenofovir disoproxil fumarate Unknown 200 mg Oral
Background Emtricitabine/Tenofovir disoproxil fumarate Unknown 300 mg Oral
Background Lopinavir/ritonavir Unknown 100 mg Oral
Background Lopinavir/ritonavir Unknown 400 mg Oral
Background Tenofovir disoproxil fumarate Small molecule 300 mg Oral
Background Zidovudine Small molecule 300 mg Oral
Background emtricitabine Other / unclassified 200 mg Oral